DEEPIKA PAKIANATHAN - 05 Feb 2025 Form 4 Insider Report for Mereo BioPharma Group plc (MREO)

Role
Director
Signature
/s/ Christine Fox, by power of attorney
Issuer symbol
MREO
Transactions as of
05 Feb 2025
Net transactions value
$0
Form type
4
Filing time
06 Feb 2025, 16:30:15 UTC
Previous filing
23 Aug 2024
Next filing
21 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MREO Share Options (Right to buy) Award $0 +55,000 $0.000000 55,000 05 Feb 2025 American Depositary Shares 55,000 $3.16 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date
F2 Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer